BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20373214)

  • 1. Counter propagation artificial neural network categorical models for prediction of carcinogenicity for non-congeneric chemicals.
    Fjodorova N; Vracko M; Jezierska A; Novic M
    SAR QSAR Environ Res; 2010 Jan; 21(1):57-75. PubMed ID: 20373214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative models for carcinogenicity prediction for non-congeneric chemicals using CP ANN method for regulatory uses.
    Fjodorova N; Vračko M; Tušar M; Jezierska A; Novič M; Kühne R; Schüürmann G
    Mol Divers; 2010 Aug; 14(3):581-94. PubMed ID: 19685274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New public QSAR model for carcinogenicity.
    Fjodorova N; Vracko M; Novic M; Roncaglioni A; Benfenati E
    Chem Cent J; 2010 Jul; 4 Suppl 1(Suppl 1):S3. PubMed ID: 20678182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the OECD (Q)SAR Application Toolbox and Toxtree for predicting and profiling the carcinogenic potential of chemicals.
    Mombelli E; Devillers J
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):731-52. PubMed ID: 21120759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of criteria used to access carcinogenicity in CPANN QSAR models versus the knowledge-based expert system Toxtree.
    Fjodorova N; Novič M
    SAR QSAR Environ Res; 2014; 25(6):423-41. PubMed ID: 24716754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology.
    Benigni R; Bossa C
    Mutat Res; 2008; 659(3):248-61. PubMed ID: 18621573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing computational toxicology models with phytochemicals.
    Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
    Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some findings relevant to the mechanistic interpretation in the case of predictive models for carcinogenicity based on the counter propagation artificial neural network.
    Fjodorova N; Novič M
    J Comput Aided Mol Des; 2011 Dec; 25(12):1159-69. PubMed ID: 22139476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the applicability domain in the case of classification predictive models for carcinogenicity based on the counter propagation artificial neural network.
    Fjodorova N; Novič M; Roncaglioni A; Benfenati E
    J Comput Aided Mol Des; 2011 Dec; 25(12):1147-58. PubMed ID: 22139475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.
    Venkatapathy R; Wang CY; Bruce RM; Moudgal C
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):209-21. PubMed ID: 18977375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening of estrogen-like chemicals based on different nonlinear classification models.
    Liu H; Papa E; Walker JD; Gramatica P
    J Mol Graph Model; 2007 Jul; 26(1):135-44. PubMed ID: 17293141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report on development of quantitative interspecies structure-carcinogenicity relationship models and exploring discriminatory features for rodent carcinogenicity of diverse organic chemicals using OECD guidelines.
    Kar S; Roy K
    Chemosphere; 2012 Apr; 87(4):339-55. PubMed ID: 22225702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting carcinogenicity of diverse chemicals using probabilistic neural network modeling approaches.
    Singh KP; Gupta S; Rai P
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):465-75. PubMed ID: 23856075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.